Nasal spray for acute migraine attacks
Part of Brain & nervous system clinical trials.
This study tests a nasal spray called zavegepant to see how well it treats migraine attacks quickly. It may help people who have frequent migraines and need a fast-acting treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with migraine (with or without aura).
- You have had at least 2 migraine attacks per month for the past 3 months.
- You are 18 years of age or older.
- You are not currently participating in another clinical trial.
- You have not used zavegepant before.
- You do not have significant nasal problems or recent nasal surgery that could affect the spray.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new class of migraine medicines, called gepants, can relieve migraine pain quickly when given in the emergency department. If you're having a migraine and haven't taken pain medication recently, you might be able to join.
This study tests how well a new acute migraine medicine, zavegepant, works and is tolerated in people who are already taking a CGRP-targeting preventive medication. It may help you find an effective treatment when you get a migraine attack.
This trial tests a new nasal spray, PRT-064040, to see if it can help treat migraine attacks. It is for adults who have had migraines for at least a year and get 2 to 8 moderate to severe migraines per month.
This trial tests if a gentle nasal stimulation device can help prevent migraines. It is for adults with frequent migraines (at least 8 days per month).
This study tests whether a numbing spray applied inside the nose can relieve ongoing migraine pain. It may help people who have both migraines and sinus-like pressure or pain.
This trial studies how well a “gepant” medicine works for different types of migraine and how tolerable it is. It may help if you have frequent migraines and you can keep a headache diary as the study asks.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.